Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of cannabinoids for controlling spasticity in persons with chronic spinal cord injury
TCTR20220329001Phase 3Unknown
- Sponsor
- Government Pharmaceutical Organization
- Start
- May 2022
- Countries
- 1
01
Overview
Phase 3 trial in spinal cord injury (SCI) and Muscle spasm, sponsored by Government Pharmaceutical Organization. Status: unknown.
02
Conditions
spinal cord injury (SCI)Muscle spasm
Beyond the preview
Go deeper on TCTR20220329001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220329001.